Clinical Trial Update: The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating exenatide's effect on alcohol self-administration in heavy drinkers with alcohol use disorder; study terminated with posted re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: Boston Medical Center | Conditions: Alcohol Use Disorder | Phase 1 | Status: TERMINATED | Results posted: 2022-02-09